Original Publication Date: 16 March, 2014
Publication / Source: Future Oncology
Authors: Thomas Van den Broeck, Lorenzo Tosco & Steven Joniau
Prostate cancer (PCa) is the most common malignancy in men in developed countries. Most patients have clinically localized and potentially indolent tumors at diagnosis; however, this disease holds third place in the leading cause of cancer deaths with 136,500 deaths in 2008 . Considering these results, the question arises, who are those men with lethal PCa?